Aarts, Pim http://orcid.org/0000-0002-9366-146X
Dudink, Koen http://orcid.org/0000-0003-4168-2311
Vossen, Allard R. J. V. http://orcid.org/0000-0002-1448-5972
van Straalen, Kelsey R. http://orcid.org/0000-0003-3305-3814
Ardon, Christine B. http://orcid.org/0000-0002-2303-4604
Prens, Errol P. http://orcid.org/0000-0002-8158-660X
van der Zee, Hessel H. http://orcid.org/0000-0002-2874-7726
Article History
Accepted: 28 June 2021
First Online: 20 July 2021
Declarations
:
: Not applicable.
: PA, KD, ARDVV, KvS and CBA have no conflicts of interest to declare. EPP has acted as a consultant, speaker, principal investigator or received grants from AbbVie, Amgen, Biogen, Celgene, Eli Lilly, JanssenāCilag, Novartis, Pfizer and UCB. HHvdZ has been an advisory board member for AbbVie, InflaRX, and a speaker for Galderma.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: HHZ was invited author for this article, PA and KD performed the literature search and data analysis. PA, KD, ARJVV, KRvS, CBA, EPP and HHvdZ wrote the text and critically revised the work.